134 related articles for article (PubMed ID: 23995807)
1. [Identification of molecules with altered expression in the brain of mouse model for Down syndrome by comprehensive analyses].
Ishihara K
Yakugaku Zasshi; 2013; 133(9):989-94. PubMed ID: 23995807
[TBL] [Abstract][Full Text] [Related]
2. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
[TBL] [Abstract][Full Text] [Related]
3. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.
Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K
Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of the immune cells and prenatal neurogenesis by the triplication of the Erg gene in mouse models of Down syndrome.
Ishihara K; Shimizu R; Takata K; Kawashita E; Amano K; Shimohata A; Low D; Nabe T; Sago H; Alexander WS; Ginhoux F; Yamakawa K; Akiba S
Brain Pathol; 2020 Jan; 30(1):75-91. PubMed ID: 31206867
[TBL] [Abstract][Full Text] [Related]
5. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
6. Increased lipid peroxidation in Down's syndrome mouse models.
Ishihara K; Amano K; Takaki E; Ebrahim AS; Shimohata A; Shibazaki N; Inoue I; Takaki M; Ueda Y; Sago H; Epstein CJ; Yamakawa K
J Neurochem; 2009 Sep; 110(6):1965-76. PubMed ID: 19645748
[TBL] [Abstract][Full Text] [Related]
7. [Is Neuron-Vascular Communication Disturbed in the Delayed Prenatal Brain Development of a Mouse Model of Down Syndrome?].
Ishihara K
Yakugaku Zasshi; 2021; 141(3):369-373. PubMed ID: 33642505
[TBL] [Abstract][Full Text] [Related]
8. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets].
Ishihara K
Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291
[TBL] [Abstract][Full Text] [Related]
9. [Copper accumulation in the brain of Down syndrome model mice and its pathophysiological significance].
Ishihara K; Kawashita E; Akiba S
Nihon Yakurigaku Zasshi; 2019; 154(6):335-339. PubMed ID: 31787686
[TBL] [Abstract][Full Text] [Related]
10. Copper accumulation in the brain causes the elevation of oxidative stress and less anxious behavior in Ts1Cje mice, a model of Down syndrome.
Ishihara K; Kawashita E; Shimizu R; Nagasawa K; Yasui H; Sago H; Yamakawa K; Akiba S
Free Radic Biol Med; 2019 Apr; 134():248-259. PubMed ID: 30660502
[TBL] [Abstract][Full Text] [Related]
11. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic profiling reveals aberrant cell proliferation in the brain of embryonic Ts1Cje, a mouse model of Down syndrome.
Ishihara K; Kanai S; Sago H; Yamakawa K; Akiba S
Neuroscience; 2014 Dec; 281():1-15. PubMed ID: 25261685
[TBL] [Abstract][Full Text] [Related]
13. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
14. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks.
Ling KH; Hewitt CA; Tan KL; Cheah PS; Vidyadaran S; Lai MI; Lee HC; Simpson K; Hyde L; Pritchard MA; Smyth GK; Thomas T; Scott HS
BMC Genomics; 2014 Jul; 15(1):624. PubMed ID: 25052193
[TBL] [Abstract][Full Text] [Related]
15. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
16. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
[TBL] [Abstract][Full Text] [Related]
18. Towards the understanding of Down syndrome using mouse models.
Yamakawa K
Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
[TBL] [Abstract][Full Text] [Related]
19. Molecular neuropathology of transgenic mouse models of Down syndrome.
Cairns NJ
J Neural Transm Suppl; 2001; (61):289-301. PubMed ID: 11771752
[TBL] [Abstract][Full Text] [Related]
20. Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome.
Seth EA; Lee HC; Yusof HHBM; Nordin N; Cheah YK; Ho ETW; Ling KH; Cheah PS
PLoS One; 2020; 15(7):e0236826. PubMed ID: 32730314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
